Acute sinusitis: Current status of etiologies, diagnosis, and treatment

Current Clinical Topics in Infectious Diseases

Volumn , Issue 21, 2001, Pages 31-63

  Chow, Anthony W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DECONGESTIVE AGENT;

ACUTE DISEASE; ADULT; BACTERIAL INFECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HISTOLOGY; HUMAN; MALE; PARANASAL SINUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINUSITIS;

ACUTE DISEASE; ADULT; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CHILD; FEMALE; HUMANS; MALE; NASAL DECONGESTANTS; PARANASAL SINUSES; RANDOMIZED CONTROLLED TRIALS; SINUSITIS;

EID: 0035236581     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (170)

1. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103: 408-414.
2. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273: 214-219.
3. Thornsberry C, Ogilvie P, Kahn J, et al. Surveillance of antimicrobial resistance in Streptococcus pneumonias, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn Microbiol Infect Dis 1997;29:249-257.
4. Stammberger HR, Kennedy DW. Paranasal sinuses: anatomic terminology and nomenclature. Ann Otol Rhinol Laryngol 1995;167(suppl): 7-16.
5. Poole MD. A focus on acute sinusitis in adults: changes in disease management. Am J Med 1999;106:38S-47S.
6. Wald ER. Sinusitis. Pediatric Annals 1998;27: 811-818.
7. Noye KA, Brodovsky D, Coyle S, et al. Classification, diagnosis and treatment of sinusitis: evidence-based clinical practice guidelines. Can J Infect Dis 1998;9(Suppl B):3B-24B.
8. Daley CL, Sande M. The running noseinfection of the paranasal sinuses. Infect Dis Clin N Am 1988;2:131-H7.
9. Sobin J, Engquist S, Nord CE. Bacteriology of the maxillary sinus in healthy volunteers. Scand J Infect Dis 1992;24:633-035.
10. Gwaltney JM Jr, et al. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 2000;30:387-391.
11. Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis 1996;23:1209-1225.
12. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci 1998;316:13-20.
13. Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: bench to bedside. Current findings, future directions [published erratum appears in J Allergy Clin Immunol 1997;100:510]. J Allergy Clin Immunol 1997;99:S829-S848.
14. Lundberg JO, Rinder J, Weitzberg E, et al. Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses. Acta Physiol Scand 1994;152:431-432.
15. Baraldi E, Azzolin NM, Biban P, Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am J Respir Crit Care Med 1997;155:1680-1683.
16. Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol 1997;117:113-117.
17. Marks SC. Acute sinusitis in the rabbit model: histologic analysis. Laryngoscope 1998;108:320-325.
18. Gnoy AR, Cannon PJ, Ganjian E, et al. A potential role for nasal obstruction in development of acute sinusitis: an infection study in rabbits. Am J Rhinol 1998;12:399-404.
19. Wagenmann M, Naclerio RM. Anatomic and physiologic considerations in sinusitis. J Allergy Clin Immunol 1992;90:419-423.
20. Scharf KE, Lawson W, Shapiro JM, Cannon PJ. Pressure measurements in the normal and occluded rabbit maxillary sinus. Laryngoscope 1995;105:570-574.
21. Rudack C, Hauser U, Wagenmann M, et al. [Cytokine pattern in various forms of sinusitis.] Laryngorhinootologie 1998;77:34-37.
22. Agency for Health Care Policy and Research. Diagnosis and treatment of acute bacterial rhinosinusitis. Evidence Report/Technololgy Assessment, no. 9. Rockville, MD: AHCPR, 1999:1-7.
23. Osguthorpe JD, Hadley JA. Rhinosinusitis: current concepts in evaluation and management. Med Clin North Am 1999;83:27-41.
24. Grant JA. Sinusitis and associated conditions. Curr Pract Med 1999;2:1767-1773.
25. Karlsson G, Holmberg K. Does allergic rhinitis predispose to sinusitis? Acta Otolaryngol Suppl 1994;515:26-28.
26. Huang SW. The risk of sinusitis in children with allergic rhinitis. Allergy Asthma Proc 2000;21: 85-88.
27. Hinriksdottir I, Melen I. Allergic rhinitis and upper respiratory tract infections. Acta Otolaryngol Suppl 1994;515:30-32.
28. Berrettini S, Carabelli A, Sellari-Franceschini S, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy 1999;54:242-248.
29. Kramer MF, Ostertag P, Pfrogncr E, Rasp G. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis. Laryngoscope 2000;110:1056-1062.
30. Wright ED, Christodoulopoulos P, Frenkiel S, Hamid Q. Expression of interleukin (IL)-12 (p40) and IL-12 (beta 2) receptors in allergic rhinitis and chronic sinusitis. Clin Exp Allergy 1999;29:1320-1325.
31. Annesi-Maesano I. Epidemiological evidence of the occurrence of rhinitis and sinusitis in asthmatics. Allergy 1999;54(suppl 57):7-13.
32. Oliveira CA, Sole D, Naspitz CK, Rachelefsky GS. Improvement of bronchial hyperresponsiveness in asthmatic children treated for concomitant sinusitis. Ann Allergy Asthma Immunol 1997;79:70-74.
33. Scadding G. The effect of medical treatment of sinusitis upon concomitant asthma. Allergy 1999;54(suPPl 57):136-140.
34. Ikeda K, Tanno N, Tamura G, et al. Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis. Ann Otol Rhinol Laryngol 1999;108: 355-359.
35. Dinis PB, Gomes A. Sinusitis and asthma: how do they interrelate in sinus surgery? Am J Rhinol 1997;11:421-428.
36. Armenaka M, Grizzanti J, Rosenstreich DL. Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels. Ann Allergy 1994;72: 507-514.
37. Herrod GH. Immunologic considerations in the child with recurrent or persistent sinusitis. Allergy Asthma Proc 1997;18:145-148.
38. George DL, Falk PS, Umberto MG, et al. Nosocomial sinusitis in patients in the medical intensive care unit: a prospective epidemiological study. Clin Infect Dis 1998;27:463-470.
39. Rouby JJ, Laurent P, Gosnach MCE, et al. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Resp Crit Care Med 1994;150:776-783.
40. Bertrand B, Rombaux P, Eloy P, Reychler H. Sinusitis of dental origin. Acta Otorhinolaryngol Belg 1997;51:315-322.
41. Isaacson G, Yanagisawa E. Cystic fibrosis and sinusitis. Ear Nose Throat J 1998;77:886-888.
42. Castillo L, Roger PM, Haddad A, et al. [Chronic sinusitis in patients infected by HIV: therapeutic strategics.] Ann Otolaryngol Chir Cervicofac 1999;116:162-166.
43. Gwaltney J Jr. Microbiology of sinusitis. In: Druce HM. Sinusitis: pathophysiology and treatment. New York: Dekker, 1994:41-56.
44. Gwaltney JM Jr. Acute community acquired bacterial sinusitis: to treat or not to treat. Can Respir J 1999;6(suppl A):46A-50A.
45. Nord CE. The role of anaerobic bacteria in recurrent episodes of sinusitis and tonsillitis. Clin Infect Dis 1995;20:1512-1524.
46. Brook I, Frazier EH, Foote PA. Microbiology of chronic maxillary sinusitis: comparison between specimens obtained by sinus endoscopy and by surgical drainage. J Med Microbiol 1997;46:430-432.
47. Maresch G, Ulm C, Solar P, Watzek G. [Etiology of odontogenic maxillary sinusitis.] HNO 1999;47:748-755.
48. Lew D, Sonthwick FS, Montgomery WW, et al. Sphenoid sinusitis. A review of 30 cases. N Engl J Med 1983;309:1149-1154.
49. Ferguson MA, Todd JK. Toxic shock syndrome associated with Staphylococcus aureus sinusitis in children. J Infect Dis 1990;161:953.
50. Hammerschlag MRCK, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14:178-182.
51. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992;15:757-763.
52. Hashigucci K, Ogawa H, Suzuki T, Kazuyama Y. Isolation of Chlamydia pneumoniae from the maxillary sinus of a patient with purulent sinusitis [letter]. Clin Infect Dis 1992;15:570-571.
53. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma [see comments]. JAMA 1991;266:225-230.
54. Savolainen S, Jousimies-Somer H, Kleemola M, Ylikoski J. Serological evidence of viral or Mycoplasma pneumoniae infection in acute maxillary sinusitis. Eur J Clin Microbiol Infect Dis 1989;8:131-135.
55. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. In: Gershwin ME, Incaudo GA. Diseases of the sinuses: a comprehensive textbook of diagnosis and treatment. Totowa, NJ: Humana, 1996:87-96.
56. Hamory BH, Sande MA, Sydnor A Jr, et al. Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 1979;139:197-202.
57. Pitkaranta A, Arruda E, Malmberg H, Hayden FG. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR. J Clin Microbiol 1997;35:1791-1793.
58. Ramadan HH, Farr RW, Wetmore SJ. Adenovirus and respiratory syncytial virus in chronic sinusitis using polymerase chain reaction. Laryngoscope 1997;107:923-925.
59. Brook I. Microbiology of nosocomial sinusitis in mechanically ventilated children. Arch Otolaryngol Head Neck Surg 1998;124:35-38.
60. Bert F, Lambert-Zechovsky N. Sinusitis in mechanically ventilated patients and its role in the pathogenesis of nosocomial pneumonia. Eur J Clin Microbiol Infect Dis 1996;15:533-544.
61. Shapiro ED, Milmoe GJ, Wald ER, et al. Bacteriology of the maxillary sinuses in patients with cystic fibrosis. J Infect Dis 1982;146:589-593.
62. Rombaux P, Bertrand B, Eloy P. Sinusitis in the immunocompromised host. Acta Otorhinolaryngol Belg 1997;51:305-313.
63. Upadhyay S, Marks SC, Arden RL, et al. Bacteriology of sinusitis in human immunodeficiency virus-positive patients: implications for management. Laryngoscope 1995;105:1058-1060.
64. Del Borgo C, Del Forno A, Ottaviani F, Fantoni M. Sinusitis in HIV-infecied patients. J Cheniother 1997;9:83-88.
65. Hunt SM, Miyamoto RC, Cornelius RS, Tami TA. Invasive fungal sinusitis in the acquired immunodeficiency syndrome. Otolaryngol Clin North Am 2000;33:335-347.
66. deShazo RD. Fungal sinusitis. Am J Med Sci 1998;316:39-45.
67. Anon JBC. Report of the Rhinosinusitis Task Force Committee Meeting. Otolaryngol Head Neck Surg 1996;117(suPPl):S1-S57.
68. Gwaltney J Jr, Phillips CD, Miller RD, et al. Computed tomographic study of the common cold. N Engl J Med 1994;330:25-30.
69. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997; 117(suppl):S1-S7.
70. Ucda D, Yoto Y. The ten-day mark as a practical diagnostic approach for acute paranasal sinusitis in children. Pediatr Infect Dis J 1996;15:576-579.
71. Williams JW Jr, Simel DL, Roberts L, Samsa GP. Clinical evaluation for sinusitis: making the diagnosis by history and physical examination. Ann Intern Med 1992;117:705-710.
72. Low DE, Desrosiers M, McSherry J, et al. A practical guide for the diagnosis and treatment of acute sinusitis [see comments]. CMAJ 1997; 156(suppl 6):S1-S14.
73. Fagnan LJ. Acute sinusitis: a cost-effective approach to diagnosis and treatment. Am Fam Physician 1998;58:1795-1796.
74. Lindbaek M, Hjortdahl P, Johnsen UL. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: comparison with computed tomography. Fam Med 1996;28:183-188.
75. Turgut S, Ozean KM, Celikkanat S, Ozdem C. Isolated sphenoid sinusitis. Rhinology 1997;35: 132-135.
76. Westergren V, Lundblad L, Hellquist HB, Forsum U. Ventilator-associated sinusitis: a review. Clin Infect Dis 1998;27:851-864.
77. Melen I, Lindahl L, Andreasson L, Rundcrantz H. Chronic maxillary sinusitis. Definition, diagnosis and relation to dental infections and nasal polyposis. Acta Otolaryngol 1986;101:320-327.
78. Cascade PNC. ACR appropriateness criteria project. Radiology 2000;214(suppl):21-25.
79. Laine K, Maatta T, Varonen H, Makela M. Diagnosing acute maxillary sinusitis in primary care: a comparison of ultrasound, clinical examination and radiography. Rhinology 1998;36:2-6.
80. Zinreich SJ. Rhiniosinusitis: radiologic diagnosis. Report of the Rhinosinusitis Task Force Committee Meeting, 1996. Otolaryngol Head Neck Surg 1997;117(suppl):S27-S34.
81. Puidupin M, Guiavarch M, Paris A, et al. B-mode ultrasound in the diagnosis of maxillary sinusitis in intensive care unit. Intensive Care Med 1997;23:1174-1175.
82. Talbot G, Kennedy D, Scheld WM, et al. Correlation of sinus endoscopy vs. sinus aspiration for microbiologic documentation of acute maxillary sinusitis (abstract). Presented at the 35th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17-20, 1995.
83. Jousimies-Somer HR, Savolainen S, Ylikoski JS. Bacteriological findings of acute maxillary sinusitis in young adults. J Clin Microbiol 1988;26: 1919-1925.
84. Brook I, Frazier EH, Foote PA. Microbiology of the transition from acute to chronic maxillary sinusitis. J Med Microbiol 1996;45:372-375.
85. de Bock GH, Dekker FW, Stolk J, et al. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol 1997;50:881-890.
86. Stalman W, van Essen GA, van der GY, de Melker RA. Maxillary sinusitis in adults: an evaluation of placebo-controlled double-blind trials. Fam Pract 1997;14:124-129.
87. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. The end of antibiotic treatment in adults wilh acute sinusitis-like complaints in general practice? A placebo-controlled doubleblind randomized doxycycline trial. Br J Gen Pract 1997;47:794-799.
88. van Buchcm FL, Knottnerus JA, Schrijnemaekers VJ, Peeters MF. Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis [sec comments]. Lancet 1997;349:683-687.
89. Kaiser L, Lew D, Hirschel B, et al. Radiological maxillary sinusitis in patients with common cold [letter]. J Fam Pract 1998;47:72-74.
90. Wald ER. Sinusitis in children. N Engl J Med 1992;326:319-323.
91. Lindbaek M, Hjortdahl P, Johnsen ULH. Randomised, double-blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ 1996;313: 325-329.
92. Kaliner M. Medical management of sinusitis. Am J Med Sci 1998;316:21-28.
93. Hinni ML, McCaffrey TV, Kasperbauer JL. Early mucosal changes in experimentl sinusitis. Otolaryngol Head Neck Surg 1992;107:537-548.
94. Melen I, Friberg B, Andreasson L, et al. Effects of phenylpropanolamine on ostial and nasal patency in patients treated for chronic maxillary sinusitis. Acta Otolaryngol 1986;101:491-500.
95. Roth RP, Cantekin VI, Bluestone CD. Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol 1987;86:235-241.
96. Aust RDB, Falck B. Studies of the effect of peroral fenylpropanolamin on the functional size of the human maxillary ostium. Acta Otolaryngol 1979;88:455-458.
97. McCormick DP, John SD, Swischuk LE, Uchida T. A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila) 1996;35:457-460.
98. Bende M, Fukami M, Arfors KE, et al. Effect of oxymetazoline nose drops on acute sinusitis in the rabbit. Ann Otol Rhinol Laryngol 1996;105:222-225.
99. Min YG, Kim HS, Suh SH, et al. Paranasal sinusitis after long-term use of topical nasal decongestants. Acta Otolaryngol 1996;116:465-471.
100. Toohill RJ, Lehman RH, Grossman TW, Belson TP. Rhinitis medicamentasa. Laryngoscope 1981;91:1614-1621.
101. Chow AW. Infections of the upper and lower respiratory tract. In: Bone R, New H. Current practice of medicine, 2nd ed. Philadelphia: W. B. Saunders, 1999:517-538.
102. Gwaltney JM Jr, Park J, Paul RA, et al. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Clin Infect Dis 1996;22:656-662.
103. Turner RB, Sperber SJ, Sorrentino JV, et al. Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold. Clin Infect Dis 1997;25: 824-830.
104. Igarashi Y, Skoncr DP, Doyle WJ, et al. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 1993;92:722-731.
105. Eggleston PA, Hendley JO, Gwaltney JM Jr, et al. Histamine in nasal secretions, Int Arch Allergy Appl Immunol 1978;57:193-200.
106. Gaffey MJ, Kaiser DL, Hayden FG. Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms. Ped Infect Dis 1988;7:223-228.
107. Berkowitz RB, Tindelman DG. Evaluation of terfenadine for treatment of the common cold. Ann Allergy 1991;67:593-597.
108. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92:812-823.
109. Barlan IB, Erkan E, Bakir M, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 1997;78:598-601.
110. Benninger MS, Anon J, Mabry RL. The medical mangement of rhinosinusitis. Otolaryngol Head Neck Surg 1997;117:S41-S49.
111. Berg O, Lejdeborn L. Experience of a permanent ventilation and drainage system in the management of purulent maxillary sinusitis. Ann Otol Rhinol Laryngol 1990;99:192-196.
112. Shoseyov D, Bibi H, Shai P, et al. Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. J Allergy Clin Immunol 1998;101:602-605.
113. Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev 2000:CD001728.
114. Marshall I. Zinc for the common cold. Cochrane Database Syst Rev 2000:CD001364.
115. Melchart D, Linde K, Fischer P, Kaesmayr J. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2000:CD000530.
116. Gananca M, Trabulsi LR. The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo-controlled study. Curr Med Res Opin 1973;1:362-368.
117. Wald ER, Chipnonis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children. A double-blind, placebo-controlled trial. Pediatrics 1986; 77:795-800.
118. Haye R, Lingaas E, Hoivik HO, Odegard T. Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. Eur J Clin Microbiol Infect Dis 199S;17:309-812.
119. Hansen JG, Schmidt H, Grinsted P. Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scand J Prim Health Care 2000;18:44-47.
120. Institute for Clinical Systems Integration. Acute sinusitis in adults. Postgraduate Med 1998; 103:154-168.
121. Brook I. Beta-lactamase producing bacteria in head and neck infection. Laryngoscope 1988;98: 428-431.
122. Chow AW. Infections of the oral cavity, neck and bead. In: Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases, 5th ed. Phildelphia Churchill Livingstone, 2000: 689-702.
123. Williams JW Jr, Holleman DR Jr, Samsa GP, Simel DL. Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis [see comments]. JAMA 1995;273:1015-1021.
124. Murray BE. The growing threat of penicillin-resistant Streptococcus pneumoniae. Infect Dis Clin Pract 1997;6(suppl 2):S21-S27.
125. Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1977 results from the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 1998;27:764-770.
126. Zhanel GG, Karlowsky JA, Palatnick L, et al. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group. Antimicrob Agents Chemother 1999;43: 2504-2509.
127. Low DE. Resistance issues and treatment implications: Pneumococcus, Staphylococcus aureus and gram negative rods. Infect Dis Clin North Am 1998;12:613-630.
128. Calhoun KH, Hokanson JA. Multicenter comparison of clarithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Arch Fam Med 1993;2:837-840.
129. Casiano RR. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Am J Med 1991;91:27-30.
130. Karma P, Pukander J, Penttila M, et al. The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis. J Antimicrob Chemother 1991;27(suppl A):83-90.
131. Dubois J, Saint-Pierre C, Tremblay C. Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis. Ear Nose Throat J 1993;72:804-810.
132. Clifford K, Huck W, Shan M, et al. Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. Ann Otol Rhinol Laryngol 1999;108: 360-367.
133. Lasko B, Lau CY, Saint-Pierre C, et al. Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. J Int Med Res 1998;26:281-291.
134. Adelglass J, Jones TM, Ruoff G, et al. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. Pharmacotherapy 1998;18:1255-1263.
135. Henry DC, Moller DJ Jr, Adelglass J, et al. Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group. Clin Ther 1999;21:340-352.
136. Gehanno P, Berchc P. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group. J Antimicrob Chemother 1996;37(suppl A):105-114.
137. Siegert R, Gehanno P, Nikolaidis P, et al. A comparison of the safety and efficacy of moxifloxatin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Respir Med 2000;94: 337-344.
138. Burke T, Villanueva C, Mariano H Jr, et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group. Clin Ther 1999;21:1664-1677.
139. Hooper DC. Expanding uses of fluoroquinolones: opportunities and challenges [editorial] [see comments]. Ann Intern Med 1998;129: 908-910.
140. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999;341:233-239.
141. Holzapfel L, Chastang C, Demingeon G, et al. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients, influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia [see comnts], Am J Respir Crit Care Med 1999;159: 695-701.
142. Rizk SS, Kraus DH, Gerresheim G, Mudan S. Aggressive combination treatment for invasive fungal sinusitis in immunocompromised patients. Ear Nose Throat J 2000;79:278-285.
143. Beste DJ, Capper DT, Shaffer K, et al. Antimicrobial effect on rabbit sinusitis after temporary ostial occlusion. Am J Rhinol 1997;11:485-489.
144. Deutsch E, Hevron I. [Endoscopic sinus surgery for extracranial complications of sinusitis.] Harefuah 2000;138:195-199, 271.
145. Kennedy DW, Wright ED, Goldberg AN. Objective and subjective outcomes in surgery for chronic sinusitis. Laryngoscope 2000;110:29-31.
146. Sobol SE, Wright ED, Frenkiel S. One-year outcome analysis of functional endoscopic sinus surgery for chronic sinusitis. J Otolaryngol 1998;27:252-257.
147. Jones RL, Violaris NS, Chavda SV, Pahor AL. Intracranial complications of sinusitis: the need for aggressive management. J Laryngol Otol 1995;109:1061-1062.
148. Mortimore S, Wormald PJ. Management of acute complicated sinusitis: a 5-year review. Otolaryngol Head Neck Surg 1999;121:639-642.
149. Barry B, Ameline E, Thuong M, et al. [Orbital complications of sinusitis in adults.] Ann Otolaryngol Chir Cervicofac 2000;117:19-25.
150. Norrelund N. Behandlung of sinusitis i almenpraksis. En kontrolleret undersogelse over pivampicillin. Ugeskr Laeger 1978;140:2792-2795.
151. Rantanen T, Arvilomi H. Double-blind trial of doxycycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngol 1973;76:58-62.
152. Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic treatment in the subset of commoncold patients who have bacteria in nasopharyngeal secretions. Lancet 1996;347:1507-1510.
153. Hayle R, Lingaas E, Hoivik HO, Odegard T. Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis. Eur J Clin Microbiol Infect Dis 1996;15:849-853.
154. Huck W, Reed BD, Nielsen RW, et al. Cefaclor vs. amoxicillin in the treatment of acute, recurrent, and chronic sinusitis. Arch Fam Med 1993;2:497-503.
155. von Sydow C, Savolainen S, Soderqvist A. Treatment of acute maxillary sinusitis-comparing cefpodoxime proxetil with amoxicillin. Scand J Infect Dis 1995;27:229-234.
156. Sydnor TA Jr, Scheld WM, Gwaltney J Jr, et al. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis. Ear Nose Throat J 1992;71:225-232.
157. Camacho AE, Cobo R, Otte J, et al. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. Am J Med 1992;93:271-276.
158. Gwaltney JM Jr, Savolainen S, Rivas P, et al. Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group. Antimicrob Agents Chemother 1997;41:1517-1520.
159. Seggev JS, Enrique RR, Brandon ML, et al. A combination of amoxicillin and clavulanate every 12 hours vs every 8 hours for treatment of acute bacterial maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1998;124:921-925.
160. Henry DC, Sydnor A Jr, Settipane GA, et al. Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis. Clin Ther 1999;21:1158-1170.
161. Steurer M, Schenk P. Efficacy and safety of cefdinir in the treatment of maxillary sinusitis. Eur Arch Otorhinolaryngol 2000;257:140-148.
162. Gehanno P, Depondt J, Barry B, et al. Comparison of cefpodoxaime proxetil with cefaclor in the treatment of sinusitis. J Antimicrob Chemother 1990;26:87-91.
163. Kohler W, Schenk P. [Cephalosporin treatment of maxillary sinusitis.] Laryngorhinootologic 1995;74:355-360.
164. Johnson PA, Rodriguez HP, Wazen JJ, et al. Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. J Otolaryngol 1999;28:3-12.
165. Pessey JJ. [Pristinamycin in the outpatient treatment of acute sinusitis in adults.] Presse Med 1999;28(suppl 1): 10-12.
166. Klein GL, Whalen E, Echols RM, Heyd A. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. J Otolaryngol 1998;27:10-16.
167. Stefansson P, Jacovides A, Jablonicky P, et al. Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. Rhinology 1998;36:173-178.
168. Zeckel ML, Johns D Jr, Masica DN, Farlow D. Twice-daily dosing of loracarbef 200 mg versus 400 mg in the treatment of patients with acute maxillary sinusitis. Clin Ther 1995;17:214-250.
169. Scandinavian Study Group. Loracarbef versus doxycycline in the treatment of acute maxillary sinusitis. J Antimicrob Chemother 1993;31:949-961.
170. Fairbanks DNF, Milmoe GJ. Complications and sequelae - an otolaryngologist's perspective. In: Bluestone CD, ed. The diagnosis and management of sinusitis in children: proceedings of a closed conference. Ped Infect Dis 1985;4(suppl 6):S75-S78.